103 related articles for article (PubMed ID: 16391843)
1. H19-DMR allele-specific methylation analysis reveals epigenetic heterogeneity of CTCF binding site 6 but not of site 5 in head-and-neck carcinomas: a pilot case-control analysis.
De Castro Valente Esteves LI; De Karla Cervigne N; Do Carmo Javaroni A; Magrin J; Kowalski LP; Rainho CA; Rogatto SR
Int J Mol Med; 2006 Feb; 17(2):397-404. PubMed ID: 16391843
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas?
Esteves LI; Javaroni AC; Nishimoto IN; Magrin J; Squire JA; Kowalski LP; Rainho CA; Rogatto SR
Mol Carcinog; 2005 Oct; 44(2):102-10. PubMed ID: 16015666
[TBL] [Abstract][Full Text] [Related]
3. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
Manoharan H; Babcock K; Pitot HC
Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
Yang Y; Hu JF; Ulaner GA; Li T; Yao X; Vu TH; Hoffman AR
J Cell Biochem; 2003 Dec; 90(5):1038-55. PubMed ID: 14624463
[TBL] [Abstract][Full Text] [Related]
5. Allele-specific methylation analysis on upstream promoter region of H19 by methylation-specific PCR with confronting two-pair primers.
Sasamoto H; Nagasaka T; Notohara K; Ozaki K; Isozaki H; Tanaka N; Matsubara N
Int J Oncol; 2004 Nov; 25(5):1273-8. PubMed ID: 15492815
[TBL] [Abstract][Full Text] [Related]
6. CTCF binding sites promote transcription initiation and prevent DNA methylation on the maternal allele at the imprinted H19/Igf2 locus.
Engel N; Thorvaldsen JL; Bartolomei MS
Hum Mol Genet; 2006 Oct; 15(19):2945-54. PubMed ID: 16928784
[TBL] [Abstract][Full Text] [Related]
7. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
[TBL] [Abstract][Full Text] [Related]
8. Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin.
Kawakami T; Zhang C; Okada Y; Okamoto K
Oncogene; 2006 Jun; 25(23):3225-36. PubMed ID: 16434968
[TBL] [Abstract][Full Text] [Related]
9. Non-random, individual-specific methylation profiles are present at the sixth CTCF binding site in the human H19/IGF2 imprinting control region.
Tost J; Jammes H; Dupont JM; Buffat C; Robert B; Mignot TM; Mondon F; Carbonne B; Siméoni U; Grangé G; Kerjean A; Ferré F; Gut IG; Vaiman D
Nucleic Acids Res; 2006; 34(19):5438-48. PubMed ID: 17012269
[TBL] [Abstract][Full Text] [Related]
10. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
Vu TH; Li T; Nguyen D; Nguyen BT; Yao XM; Hu JF; Hoffman AR
Genomics; 2000 Mar; 64(2):132-43. PubMed ID: 10729220
[TBL] [Abstract][Full Text] [Related]
11. CTCF maintains differential methylation at the Igf2/H19 locus.
Schoenherr CJ; Levorse JM; Tilghman SM
Nat Genet; 2003 Jan; 33(1):66-9. PubMed ID: 12461525
[TBL] [Abstract][Full Text] [Related]
12. CTCF binding is not the epigenetic mark that establishes post-fertilization methylation imprinting in the transgenic H19 ICR.
Matsuzaki H; Okamura E; Fukamizu A; Tanimoto K
Hum Mol Genet; 2010 Apr; 19(7):1190-8. PubMed ID: 20047949
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic status of the H19 locus in human oocytes following in vitro maturation.
Borghol N; Lornage J; Blachère T; Sophie Garret A; Lefèvre A
Genomics; 2006 Mar; 87(3):417-26. PubMed ID: 16378710
[TBL] [Abstract][Full Text] [Related]
15. Methylation status of putative differentially methylated regions of porcine IGF2 and H19.
Han DW; Im YB; Do JT; Gupta MK; Uhm SJ; Kim JH; Schöler HR; Lee HT
Mol Reprod Dev; 2008 May; 75(5):777-84. PubMed ID: 18247333
[TBL] [Abstract][Full Text] [Related]
16. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
[TBL] [Abstract][Full Text] [Related]
17. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene.
Bell AC; Felsenfeld G
Nature; 2000 May; 405(6785):482-5. PubMed ID: 10839546
[TBL] [Abstract][Full Text] [Related]
18. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
Sparago A; Cerrato F; Vernucci M; Ferrero GB; Silengo MC; Riccio A
Nat Genet; 2004 Sep; 36(9):958-60. PubMed ID: 15314640
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
[TBL] [Abstract][Full Text] [Related]
20. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
